Articles

  1. OSO Biopharmaceuticals Capabilities Overview 1/3/2014

    OSOBio is a contract manufacturing organization (CMO) that focuses on biologic and pharmaceutical injectable finished drug products- (sterile liquid, liquid suspension and lyophilized formulations)

  2. OSO Biopharmaceuticals Brochure 1/3/2014

    OsoBio delivers the sterile contract manufacturing and drug development services you require - regardless of the scale or complexity of your sterile injectable.

  3. Anticipating Success: Meeting The Inherent Challenges Of Complex Drug Substances 9/17/2013

    Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages.

  4. The Environmental Impact of Clinical Trials 8/8/2013

    For many years it has been almost universally accepted that there are various sources that may impact or cause disease among which biological, social, and environmental differences have all been investigated. Many clinical trials have been conducted to assess the impact of the environment on outcomes e.g., the effect of the environment on the outcome of studies assessing the efficacy of drugs for patients with dry-eye syndrome, the impact of diet on obesity and cardiovascular disease, and the impact of the environment on autoimmune diseases have all been studied, as have many other interactions.

  5. Adding Value To The Drug Development Process 4/30/2012

    Life science companies can gain advantages from working with external partners that can bridge the divide between drug development and commercialization. By William Crown, Ph.D.

  6. Kemwell Overview 3/29/2012
    Manufacturing customers include top pharmaceutical companies – Allergan, Bayer, GSK, J&J, Pfizer, Teva, and Novartis, as well as small emerging biotech.
  7. Kemwell Biopharma Brochure 3/29/2012
    Kemwell Biopharma will offer services ranging from full-service process development, manufacture, formulation and fill and finish at the cGMP manufacturing facility in Bangalore, India as a one-stop-shop through access to Boehringer Ingelheim's® cell line development with the BI HEX technology platform, followed by a preferred access to the large-scale commercial production of Boehringer Ingelheim at its facilities in Europe.
  8. Sterile Clinical Trial Material Formulation & Filling 3/26/2012
    DSM offers sterile clinical trial formulation and filling that meets the unique needs of global pharmaceutical and biotech customers.
  9. Cytotoxic Formulation & Filling 3/26/2012
    DSM expanded their commercial-scale sterile pharmaceutical services by offering filling and lyophilization of cytotoxic products.
  10. Brochure: Finished Dosage Forms 2/21/2012
    DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.